HighTower Advisors LLC Has $22.68 Million Stake in Agilent Technologies, Inc. $A

HighTower Advisors LLC lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 166,642 shares of the medical research company’s stock after buying an additional 4,746 shares during the quarter. HighTower Advisors LLC’s holdings in Agilent Technologies were worth $22,675,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Flynn Zito Capital Management LLC grew its position in shares of Agilent Technologies by 3.2% during the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after buying an additional 69 shares during the period. Gabelli Funds LLC grew its holdings in Agilent Technologies by 1.1% during the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after purchasing an additional 74 shares during the period. Fiduciary Trust Co grew its holdings in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares during the period. NorthCrest Asset Manangement LLC grew its holdings in Agilent Technologies by 1.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after purchasing an additional 79 shares during the period. Finally, Freestone Capital Holdings LLC grew its holdings in Agilent Technologies by 2.0% during the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after purchasing an additional 84 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Stock Up 0.2%

Agilent Technologies stock opened at $115.01 on Friday. The stock has a market capitalization of $32.50 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. Agilent Technologies, Inc. has a twelve month low of $107.07 and a twelve month high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The company has a 50 day moving average of $114.77 and a 200-day moving average of $129.56.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 22.52%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. UBS Group decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. TD Cowen decreased their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, Barclays decreased their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of “Buy” and an average target price of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.